Concepedia
Statistics
Publications
31
Citations
1.2K
H-Index
24
Active since
1990
Affiliations
Amgen (United States)(Current)
Eli Lilly (United States)
University of Nottingham
Yale University
Sanofi (United States)
Stephen A. Hitchcock is an author at Amgen (United States) specializing in pharmacology, medicine, and biochemistry.
Top concepts
PharmacologyMedicineBiochemistryDrug DiscoveryNatural SciencesMedicinal ChemistryPharmacotherapyEngineeringChemical BiologyDrug Development
Publications per year
1990–2015
From Fragment Screening to In Vivo Efficacy: Optimization of a Series of 2-Aminoquinolines as Potent Inhibitors of Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1)
Yuan Cheng, Ted Judd, Michael D. Bartberger et al. · Journal of Medicinal Chemistry · 2011 · 136 citations · Full text
A tandem radical macrocyclisation - radical transannulation strategy to the taxane ring system
Stephen A. Hitchcock, Gerald Pattenden · Tetrahedron Letters · 1992 · 74 citations
Bioorganic Chemistry, Engineering, Heterocyclic +12
A Convergent Total Synthesis of Calicheamicin γ
Stephen A. Hitchcock, Serge H. Boyer, Margaret Y. Chu‐Moyer et al. · Angewandte Chemie International Edition in English · 1994 · 70 citations
Design and Preparation of a Potent Series of Hydroxyethylamine Containing β-Secretase Inhibitors That Demonstrate Robust Reduction of Central β-Amyloid
Matthew M. Weiss, Toni Williamson, Safura Babu‐Khan et al. · Journal of Medicinal Chemistry · 2012 · 63 citations · Full text
A Remarkable Glycosidation Reaction: The Total Synthesis of Calicheamicin .gamma.1I
Stephen A. Hitchcock, Margaret Y. Chu‐Moyer, Serge H. Boyer et al. · Journal of the American Chemical Society · 1995 · 59 citations
Biosynthesis, Bioorganic Chemistry, Engineering +15
1–5 of 31